These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8314173)

  • 1. Haemostasis unbalance in Pugh-scored liver cirrhosis: characteristic changes of plasma levels of protein C versus protein S.
    De Caterina M; Tarantino G; Farina C; Arena A; di Maro G; Esposito P; Scopacasa F
    Haemostasis; 1993; 23(4):229-35. PubMed ID: 8314173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
    Zhang D; Hao J; Yang N
    J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of fibrotic, haemostatic and endotoxic changes in patients with liver cirrhosis.
    Li CJ; Yang ZH; Lu FG; Shi XL; Liu DL
    Acta Gastroenterol Belg; 2018; 81(3):404-409. PubMed ID: 30350529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in levels of blood coagulation inhibitors in cirrhosis. Prospective study in 33 patients].
    Dumontier I; Alhenc-Gelas M; Chatellier G; Brenet P; Aiach M; Petite JP
    Gastroenterol Clin Biol; 1992; 16(2):120-5. PubMed ID: 1314744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation inhibitors in alcoholic liver cirrhosis.
    Raya-Sánchez JM; González-Reimers E; Rodríguez-Martín JM; Santolaria-Fernández F; Molina-Pérez M; Rodríguez-Moreno F; Martínez-Riera A
    Alcohol; 1998 Jan; 15(1):19-23. PubMed ID: 9426833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic changes in patients with liver cirrhosis.
    Ho CH; Hou MC; Lin HC; Lee FY; Wu JC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):376-82. PubMed ID: 10389296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of haemostatic parameters in five cases of Amanita phalloides poisoning.
    Christen Y; Minazio P; de Moerloose P
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):627-30. PubMed ID: 8218860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of coagulation factors in severity categorization of hepatitis B-related liver cirrhosis].
    Li Q; Wang BE; Cong YL; Jia JD; Yin ZJ; Qian LX; Ma H
    Zhonghua Nei Ke Za Zhi; 2005 Mar; 44(3):188-90. PubMed ID: 15840257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.
    Wang Y; Liu Y; Han R; Zhu Z; Zhang Y; Wang X; Wang L; Shen Z
    Thromb Res; 2008; 122(2):161-6. PubMed ID: 18048090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of desmopressin on hemostasis in patients with liver cirrhosis.
    Agnelli G; Parise P; Levi M; Cosmi B; Nenci GG
    Haemostasis; 1995; 25(5):241-7. PubMed ID: 7489963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III versus prothrombin in liver cirrhosis.
    Aurousseau MH; d'Angeli JL; Josso F
    Haemostasis; 1981; 10(2):104-7. PubMed ID: 7461504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial.
    Ricci G; Cerneca F; Simeone R; Pozzobon C; Guarnieri S; Sartore A; Pregazzi R; Guaschino S
    Hum Reprod; 2004 Apr; 19(4):838-48. PubMed ID: 15016779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alterations of hemostasis in liver cirrhosis of the dog].
    Mischke R; Pöhle D; Schoon HA; Fehr M; Nolte I
    Dtsch Tierarztl Wochenschr; 1998 Feb; 105(2):43-7. PubMed ID: 9528205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
    Fujii Y; Sugawa C; Ozawa T; Nakumura R; Brown-Castillo J; Mammen EF
    Am Surg; 1991 Apr; 57(4):222-5. PubMed ID: 1711300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimation of plasma protein C, protein S and antithrombin III in patients with chronic liver diseases and its clinical significance].
    Tang ZD; Wang XF; Hu XE
    Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):722-4, 767-8. PubMed ID: 2534591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.